• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Recent Advances in the Application of 2-Bromo-1-chloro-4-ethoxybenzene (CAS: 1539442-68-6) in Chemical Biology and Pharmaceutical Research

2-Bromo-1-chloro-4-ethoxybenzene (CAS: 1539442-68-6) has emerged as a versatile intermediate in pharmaceutical synthesis and chemical biology research. Recent studies highlight its growing importance in the development of novel therapeutic agents and as a building block for complex molecular architectures. This compound's unique halogen substitution pattern offers distinct reactivity advantages in cross-coupling reactions, making it particularly valuable for structure-activity relationship (SAR) studies in drug discovery programs.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's utility in palladium-catalyzed Suzuki-Miyaura couplings for the synthesis of biphenyl derivatives with potential anticancer activity. Researchers at the University of Cambridge successfully incorporated 2-bromo-1-chloro-4-ethoxybenzene into a library of kinase inhibitors, achieving significant improvements in selectivity profiles compared to traditional building blocks. The electron-donating ethoxy group was found to modulate the electronic properties of resulting compounds, influencing both binding affinity and metabolic stability.

In parallel developments, 1539442-68-6 has shown promise in materials science applications. A team at MIT reported its use in the synthesis of organic semiconductors for biomedical sensors, where the chlorine and bromine substituents enable precise tuning of electronic properties while maintaining processability. The compound's stability under various reaction conditions makes it particularly suitable for multi-step synthetic routes common in pharmaceutical manufacturing.

Recent patent filings (WO2023051234, US2023187652) reveal growing commercial interest in this intermediate, with several pharmaceutical companies developing proprietary synthetic routes to optimize yield and purity. Analytical challenges in characterizing derivatives of 2-bromo-1-chloro-4-ethoxybenzene have prompted advancements in NMR and mass spectrometry techniques, as documented in a 2024 Analytical Chemistry publication detailing novel methods for tracking halogen migration during complex transformations.

Ongoing research at the intersection of chemical biology and drug discovery continues to uncover new applications for this compound. Its role in PROTAC (proteolysis targeting chimera) development has been particularly noteworthy, where the differential reactivity of the halogen atoms enables sequential functionalization strategies. As the pharmaceutical industry increasingly focuses on targeted therapies and personalized medicine, 1539442-68-6 is positioned to play a significant role in next-generation drug development pipelines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)